Metabolic dysfunction-associated steatohepatitis (MASH) is often referred to as a “silent disease,” as it typically shows no signs of symptoms in early stages. But it can come with certain ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

List your movie, TV & celebrity picks.

Last week's survey by the British Potato Council revealed that we prefer mash to chips. So is this good news for our health? Nutritionally speaking, both mash and chips are good sources of energy ...

Keep reading to learn about the link between obesity and MASH and how to reduce your risk of this disease. “MASH is a dysfunction of the liver caused by excess fat cells,” says Mir Ali ...

$550/wk Large yard and in a great location !